HIV associated nephropathy risk factors

Jump to navigation Jump to search

HIV associated nephropathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating HIV associated nephropathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

KUB X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

HIV associated nephropathy risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of HIV associated nephropathy risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on HIV associated nephropathy risk factors

CDC on HIV associated nephropathy risk factors

HIV associated nephropathy risk factors in the news

Blogs on HIV associated nephropathy risk factors

Directions to Hospitals Treating HIV associated nephropathy

Risk calculators and risk factors for HIV associated nephropathy risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[2]

Overview

The risk factors that attribute to HIV-associated nephropathy are similar to those seen with HIV. Positive predicators for HIV-associated nephropathy include: polymorphysim of Apolipoproetin-1 (APOL1) gene, high viral load, low CD-4 count, proteinuria (nephrotic range), and higher level of renal echogenicity on ultrasound.[1]

Risk Factors

The majority of patients developing HIV-associated nephropathy, is through the acquisition of HIV-1. The acquisition of the disease can be attributed to unprotected sexual relations between partners (one partner having HIV), sharing of needles, and or contaminated blood transfusions. However, the greatest risk factor attributed to development of HIV-associated nephropathy is the black race.[2][3][4]

The predictors for the development of HIV-associated nephropathy include:[1]

Positive predictors for the development of HIV-associated nephropathy  

Negative predictors for the development of HIV-associated nephropathy  

References

  1. 1.0 1.1 Waheed S, Atta MG (2014). "Predictors of HIV-associated nephropathy". Expert Rev Anti Infect Ther. 12 (5): 555–63. doi:10.1586/14787210.2014.901170. PMID 24655211.
  2. Szczech LA (2001). "Renal diseases associated with human immunodeficiency virus infection: epidemiology, clinical course, and management". Clin Infect Dis. 33 (1): 115–9. doi:10.1086/320893. PMID 11389504.
  3. Naicker S, Fabian J (2010). "Risk factors for the development of chronic kidney disease with HIV/AIDS". Clin Nephrol. 74 Suppl 1 ( ): S51–6. PMID 20979964.
  4. Foy MC, Estrella MM, Lucas GM, Tahir F, Fine DM, Moore RD; et al. (2013). "Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy". Clin J Am Soc Nephrol. 8 (9): 1524–32. doi:10.2215/CJN.10991012. PMC 3805081. PMID 23685946.
  5. Bigé N, Lanternier F, Viard JP, Kamgang P, Daugas E, Elie C; et al. (2012). "Presentation of HIV-associated nephropathy and outcome in HAART-treated patients". Nephrol Dial Transplant. 27 (3): 1114–21. doi:10.1093/ndt/gfr376. PMID 21745806.
  6. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI; et al. (2010). "Association of trypanolytic ApoL1 variants with kidney disease in African Americans". Science. 329 (5993): 841–5. doi:10.1126/science.1193032. PMC 2980843. PMID 20647424.
  7. Lescure FX, Flateau C, Pacanowski J, Brocheriou I, Rondeau E, Girard PM; et al. (2012). "HIV-associated kidney glomerular diseases: changes with time and HAART". Nephrol Dial Transplant. 27 (6): 2349–55. doi:10.1093/ndt/gfr676. PMID 22248510.
  8. Atta MG, Choi MJ, Longenecker JC, Haymart M, Wu J, Nagajothi N; et al. (2005). "Nephrotic range proteinuria and CD4 count as noninvasive indicators of HIV-associated nephropathy". Am J Med. 118 (11): 1288. doi:10.1016/j.amjmed.2005.05.027. PMID 16271919.
  9. 9.0 9.1 Berliner AR, Fine DM, Lucas GM, Rahman MH, Racusen LC, Scheel PJ; et al. (2008). "Observations on a cohort of HIV-infected patients undergoing native renal biopsy". Am J Nephrol. 28 (3): 478–86. doi:10.1159/000112851. PMID 18176076.
  10. 10.0 10.1 Atta MG, Longenecker JC, Fine DM, Nagajothi N, Grover DS, Wu J; et al. (2004). "Sonography as a predictor of human immunodeficiency virus-associated nephropathy". J Ultrasound Med. 23 (5): 603–10, quiz 612-3. doi:10.7863/jum.2004.23.5.603. PMID 15154526.
  11. Atta MG, Estrella MM, Kuperman M, Foy MC, Fine DM, Racusen LC; et al. (2012). "HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics". Kidney Int. 82 (3): 338–43. doi:10.1038/ki.2012.111. PMC 3463138. PMID 22495294.
  12. Estrella M, Fine DM, Gallant JE, Rahman MH, Nagajothi N, Racusen LC; et al. (2006). "HIV type 1 RNA level as a clinical indicator of renal pathology in HIV-infected patients". Clin Infect Dis. 43 (3): 377–80. doi:10.1086/505497. PMID 16804855.
  13. Izzedine H, Acharya V, Wirden M, Cluzel P, Sene D, Lucas GM; et al. (2011). "Role of HIV-1 DNA levels as clinical marker of HIV-1-associated nephropathies". Nephrol Dial Transplant. 26 (2): 580–3. doi:10.1093/ndt/gfq414. PMID 20624771.

Template:WH Template:WS